Lectures 20-28 Flashcards
what are the sources of cholesterol?w
diet, and endogenous synthesis
what cells are able to synthesize chol? what is the main organ for synthesis?
almost all cells (incl brain) can synth. liver is main location.
what makes the cholesterol molecule polar?
the OH (hydroxy) group attached to one of the 6 membered rings
what can happen to make cholesterol non-polar? what occurs when this happens?
the OH can be replaced by a long chain fatty acid. (ie, esterified). then can no longer go into lipid bilayer, and forms lipid droplets in macrophages
what form is cholesterol transported in in plasma?
plasma cholesterol is in esterified form (less polar/more hydrophobic than usual). has to be transported in association with proteins.
what are the 3 sources of liver cholesterol?
- dietary
- recycled from other tissues
- de novo synthesis
what are the 3 routes by which cholesterol leaves the liver?
- via secretion in VLDL
- free cholesterol secreted in bile
- conversion to bile salts/acids
what is the precursor to cholesterol synthesis? what pathway comes prior to chol synthesis?
Acetyl-CoA. same Acetyl-CoA pool that provides the precursors for fatty acids (ie citrate from TCA is abundant, so diffuses out of the mitochondria)
where in the cell does de novo synthesis of cholesterol occur?
cytoplasm.
what is the general process of making a cholesterol, starting with Acetyl-CoA and going up to Mevalonic Acid?
2 Acetyl CoA -> Acetoacetyl CoA -> HMG CoA -> Mevalonic Acid (using HMG CoA reductase to obtain Mevalonic Acid)
what is the general process of making a cholesterol, starting with Mevalonic Acid and going up to cholesterol?
Mevalonic Acid (6C) -> Isopentenyl phrophosphate (IPP) (5C) -> 10C molec -> 15C molec -> Squalene (30C) -> Lanosterol (30C) -> cholesterol (27C)
What controls the synthesis/activity of HMG CoA Reductase?
inhibited by statins, inhibited by cholesterol
what is Smith-Lemli-Optiz syndrome (SLOS)?
genetic disorder, partial deficiency of 7-dehydroholesterol-7-reductase, involved in final step of chol synthesis. causes a variety of symptoms including retardation and phys abnormalities
How does chol enter body cells?
using the LDL receptor pathway. all cells contain the LDL receptor. LDL binds to receptor, is taken into cell, fuses with lysosome, cholesterol ester is hydrolized into free cholesterol and fatty acids.
how does cholesterol travel in the blood?
in LDL with protein (ApoB100).
what happens to the ApoB100 when the LDL is taken into a cell?
degraded to amino acids.
where does the free cholesterol go once in the cell? what effect does it have
moves to plasma membrane or to ER to regulate via SREPB pathway (regulates HMG Reductase and LDL Receptor genes). Also upregulates cholesterol storage enzyme ACAT1
what is the main control point for cholesterol synthesis?
HMG-CoA reductase, step from HMG-CoA to Mevalonic Acid
what controls expression of the HMG-CoA reductase gene? where does it bind?
a transcription factor, SREBP (sterol regulatory element binding protein). binds to the SRE located upstream of the HMG-CoA reductase gene
where is SREPB usually located? what happens when it is cleaved?
on the ER membrane. once cleaved, travels to the nucleus, upregulates transcription of HMG-CoA reductase gene.
what happens when cellular cholesterol levels are low?
SREBP travels to nucleus and upregulates transcription of HMG-CoA reductase gene.
what inhibits activity of the SREBP?
cholesterol (meaning that there is sufficient cellular cholesterol, and the cell does not need to use HMG-CoA Reductase and make more).
Activation of SREBP also activates what?
the LDL receptor gene so chol can be taken up by the cell
HMG-CoA Reductase is also hormonally regulated. what is the effect of insulin? glucagon?
insulin upregulates expression of HMG-CoA Reductase. glucagon downregulates it. Makes sense: remember precursor of cholesterol is excess cytoplasmic Acetyl-CoA from TCA spillover
how do statin drugs inhibit HMG CoA Reductase? what do they do to plasma cholesterol levels?
they are competitive inhibitors and thereby reduce cellular cholesterol synthesis. due to less chol, SREBP levels increase and increase the transcription of HMG-CoA Reductase AND upregulate LDL receptor genes. therefore decrease plasma cholesterol by making it be taken into cells
what is ACAT?
key enzyme in cellular cholesterol storage in various cells. catalyzes cholesterol -> cholesterol ester (for cellular droplet storage)
what controls ACAT?
not SREBP (too slow, requires faster regulation). controlled by its own substrate (cholesterol). this is the first defense against high cholesterol levels
how is the synthesis of cholesterol and fatty acids primarily regulated?
at the gene/transcription level
when the free cholesterol increases in a cell, what happens to the LDL receptor levels?
they decline because the cell doesn’t need to take up as much free chol.
when the free chol decreases in a cell, what happens to LDL receptor levels? what about HMG CoA Reductase levels?
LDL receptors increase to take in more circulating cholesterol. HMG CoA reductase is increasingly transcribed/translated in order to synthesize more chol de novo
how were SREBPs located experimentally?
based on their ability to bind to SREs
SREBP-1: what is it primarily involved with?
regulation of fatty acid synthesis
SREBP-2: what is it primarily involved with?
regulation of chol synthesis
what is unique about SREBP-2 as a tsn factor?
it is very large and is located in the ER.
how is SREBP-2 activated?
when there is insufficient cellular cholesterol, part of SCAP (touches SREBP normally) moves and SCAP changes shape. SREBP then drifts to Golgi where it is cleaved into a more normal-sized transcription factor and can diffuse into nucleus.
SREBP-1 clipping off from ER to go to nucleus is promoted by what?
insulin (sufficient insulin -> cleavage/activation of SREBP-1 -> Fatty acid synthesis/storage)
what genes are turned on by SREBP?
ACL, ACC, FAS
SREBP-1 generally mediates what?
insulin
if SREBP-1 mediates insulin, and SREBP-2 mediates cholesterol, then what mediates glucose?
CHREBP (carbohydrate response element binding protein)
how does CHREBP work?
similar to SREBPs: lives in cytosol, when high glucose levels, CHREBP is dephosphorylated, moves to nucleus, binds to DNA location (E-box), activates tsn.
what are required to translate Fatty Acid synthesis genes (FAS, ACC, ACL)?
both SRE and CHRE locations, activated by SREBP-1 and CHREBP
cholesterol is the obligatory precursor for biosynthesis of what 2 classes of molecules?
oxysterols and steroid hormones.
what do oxysterols do?
they have impt regulatory roles (via signal transduction) in cellular cholesterol homeostasis
what do steroid hormones do?
involved in regulatory processes in intermediary metabolism (more in endocrine course)
what are the 4 oxysterols we should be familiar with?
- 7a-hydroxycholesterol
- 24S-hydroxy cholesterol
- 27-hydroxycholesterol
- 25-hydroxycholesterol
what does 7a-hydroxycholesterol do?
first intermediate in the bile acid synthesis pathway. uses cholesterol as a substrate.
what does 24S-hydroxy cholesterol do?
most abundant oxysterol produced in the brain. the enzyme cholesterol 24S hydroxylase converts cholesterol to a more hydrophilic form to allow its release from the brain
what do 27-hydroxycholesterol and 25-hydroxycholesterol do?
impt in signaling/regulatory compounds
ACAT: regulated by SREBP?
No! regulated by its substrate (cholesterol)
the most impt rate-limiting step in the cholesterol biosynthetic pathway is:
conversion of HMG-CoA to mevalonic acid by HMG-CoA reductase
what is the mutation in familial hypercholesterolemia?
mutation in the LDL receptor gene
what does ACAT do?
converts cholesterol (with OH hydroxy group) to cholesterol ester (with FA instead of OH). the esterified form can not go into the membrane and instead is stored as a lipid droplet in macrophages (foamy cells)
why does cholesterol travel with proteins?
it’s insoluble - if it’s free in the cell it will precipatate and can cause damage. so it travels in a complex with proteins.
What do NPC 1 and NPC 2 do?
they are involved with cholesterol trafficing within the cell – allow cholesterol to move from lysosome to ER and complete endocytosis process
what happens to patients with NPC 1 and 2 deficiency?
Niemann-Pick Type C disease: progressive neurodegenerative disease. hepatic enlargement and slow dis-coordination, retardation.
where do the cholesterol molecs accumulate within the cell in NPC disease?
inside the lysosome
what is the difference between NPC 1 and NPC 2 proteins?
NPC1 is a membrane protein
NPC2 is a soluble protein
but both bind cholesterol very tightly and coordinate the movement of cholesterol within the cell (particularly, egress out of the lysosome)
if NPC1 and NPC2 are both absent, how does cholesterol move within the cell at all?
there are other pathways for cholesterol movement that are not NPC dependent: de novo synthesis and transport to the cytoplasm, and the cholesterol/cholesterol-ester cycle coordinated by ACAT
for NPA and NPB diseases, where is the mutation?
at the lysosomal sphingomyelinase (causes accumulation of sphingomyelin in the lysosome)